A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models (Q44277060)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 January 2010
edit
Language Label Description Also known as
English
A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models
scientific article published on 6 January 2010

    Statements

    A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models (English)
    Maria Pinzon-Ortiz
    Brenda McDermott

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit